Silver Book Fact

5 years of treatment with beta-blockers for heart failure increases patient survival by about 3 1/2 months and patients had fewer overnight hospital stays.

Economic Effects of Beta-Blocker Therapy in Patients with Heart Failure. The American Journal of Medicine Web site. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14715324&dopt=Abstract. Published 2004

Reference

Title
Economic Effects of Beta-Blocker Therapy in Patients with Heart Failure
Publication
The American Journal of Medicine
Publisher
Elsevier
Publication Date
Published 2004
Authors
Cowper, P.A., E. DeLong, D.J. Whellan, N.M. Allen LaPointe, and R.M. Califf
Volume & Issue
Volume 116, Issue 2
Pages
104-111
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Eliminating out-of-pocket drug costs for combination pharmacotherapy for the 423,000 Americans with drug insurance who will experience their first myocardial infarction in 2006 would save 4,736 lives, and would save…  
  • New approaches are under development to reduce ischemic stroke damage and other damage occuring because of stroke.  
  • The use of ACE inhibitors in hypertensive patients 80 years of older was associated in this study with a 30% reduction in the rate of stroke and a 64% reduction…  
  • “Coronary heart disease spending has increased more than 40% over the past 15 years, and, as a whole, the health improvements have been well worth the costs. Over the entire…  
  • Direct thrombin inhibitor reduced relative risk of venous thromboembolism
    An investigational direct thrombin inhibitor reduced relative risk of venous thromboembolism after total hip replacement surgery by 65.7%—compared to a currently available treatment.